We are live on
!
Find out more
ClearBridge Investments Portfolio holdings
AUM
$115B
1-Year Est. Return
24.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.22%
1 Year Est. Return
+24.78%
3 Year Est. Return
+90.16%
5 Year Est. Return
+117.12%
10 Year Est. Return
+468.76%
AUM
$106B
AUM Growth
-$2.26B
(-2.1%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
19.49%
Holding
1,239
New
65
Increased
399
Reduced
411
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$378M |
| 2 |
Caterpillar
CAT
|
+$333M |
| 3 |
AGN
Allergan plc
AGN
|
+$294M |
| 4 |
PX
Praxair Inc
PX
|
+$226M |
| 5 |
Oracle
ORCL
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$286M |
| 2 |
MON
Monsanto Co
MON
|
+$271M |
| 3 |
COL
Rockwell Collins
COL
|
+$263M |
| 4 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$205M |
| 5 |
Kimberly-Clark
KMB
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.65% |
| 2 | Healthcare | 18.12% |
| 3 | Financials | 11.61% |
| 4 | Communication Services | 11.54% |
| 5 | Industrials | 9.27% |
Similar funds
VAM
ClearBridge Investments's Q1 2018 Portfolio in Review
As of Q1 2018, ClearBridge Investments held 1,239 positions worth $106B, down 2.1% from $108B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
ClearBridge Investments's Q1 2018 filing shows 65 new, 399 increased, 411 reduced and 47 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 1,780,176 shares worth $94.1M. The largest sale was Amgen, an estimated $286M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- ClearBridge Investments's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 1,780,176 shares worth $94.1M.
- ClearBridge Investments added most to Equinix in Q1 2018, an estimated $378M increase.
- ClearBridge Investments's biggest Q1 2018 reduction was Amgen, cutting an estimated $286M.
- ClearBridge Investments fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $205M.
- ClearBridge Investments's ten largest holdings make up 19% of its $106B portfolio in Q1 2018.
- ClearBridge Investments opened 65 new positions and closed 47 in Q1 2018.
- ClearBridge Investments's portfolio value fell 2.1% quarter-over-quarter to $106B.
Based on ClearBridge Investments's 13F filing for Q1 2018, filed 15 May 2018.